Selected data models

You must log in to select data models for download or further analysis.

14 Search results.
Relevance Rating New first Old first

Endometrial Cancer NCT00942357 Follow-Up - Follow-Up Form (Q) - 2843361v1.0 - Follow-Up Form (Q)

- 1/9/15 - 1 form, 8 itemgroups, 32 items, 1 language
Itemgroups: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS
Follow-Up Form (Q) Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=644E86D7-D4D5-D7C8-E040-BB89AD4321CC

Endometrial Cancer NCT00807768 Follow-Up - GOG-0249 Follow-Up Form - 2758826v1.0 - GOG-0249 Follow-Up Form

- 1/9/15 - 1 form, 8 itemgroups, 32 items, 1 language
Itemgroups: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS
GOG-0249 Follow-Up Form Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F54A57A-175D-1F59-E044-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Z1031: Extended Follow-up Form - 2316464v3.0 - Z1031: Extended Follow-up Form

- 1/9/15 - 1 form, 5 itemgroups, 21 items, 1 language
Itemgroups: Header Module, Header, Notice of First Recurrence/Progression, Notice of New Primary, Footer Module
Z1031: Extended Follow-up Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FAD6C4E6-87C2-1268-E034-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Z1031: Early Termination of Follow-up (ETFU) - 2316526v3.0 - Z1031: Early Termination of Follow-up (ETFU)

- 1/9/15 - 1 form, 3 itemgroups, 10 items, 1 language
Itemgroups: Header Module, Header, Footer Module
Z1031: Early Termination of Follow-up (ETFU) Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FAD5B1B8-C17F-0689-E034-0003BA3F9857

Endometrial Cancer NCT00063999 Follow-Up - Follow-Up Form, GOG-0209, Form Q - 2077545v3.0 - Follow-Up Form, GOG-0209, Form Q

- 1/9/15 - 1 form, 9 itemgroups, 35 items, 1 language
Itemgroups: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, FOOTER MODULE, CCRR MODULE
Follow-Up Form, GOG-0209, Form Q Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B240426A-8527-0F73-E034-0003BA12F5E7

Endometrial Cancer NCT00265759 Follow-Up - Operative - Reports Form - 2427172v1.0 - Operative - Reports Form

- 1/9/15 - 1 form, 3 itemgroups, 9 items, 1 language
Itemgroups: Header Module, Header, Footer
Operative - Reports Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=051461F3-A535-72A9-E044-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Miscellaneous - Reports Form - 2427135v1.0 - Miscellaneous - Reports Form

- 1/9/15 - 1 form, 3 itemgroups, 10 items, 1 language
Itemgroups: Header Module, Header, Footer
Miscellaneous - Reports Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=05145510-13D8-711A-E044-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Mammogram - Reports Form - 2427063v1.0 - Mammogram - Reports Form

- 1/9/15 - 1 form, 3 itemgroups, 9 items, 1 language
Itemgroups: Header Module, Header, Footer
Mammogram - Reports Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=05129D06-2D9E-635D-E044-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Pathology - Reports Form - 2427204v1.0 - Pathology - Reports Form

- 1/9/15 - 1 form, 3 itemgroups, 9 items, 1 language
Itemgroups: Header Module, Header, Footer
Pathology - Reports Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=05146325-44DA-7256-E044-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Ultrasound - Reports Form - 2427235v1.0 - Ultrasound - Reports Form

- 1/9/15 - 1 form, 3 itemgroups, 9 items, 1 language
Itemgroups: Header Module, Header, Footer
Ultrasound - Reports Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0514688D-BDAA-7332-E044-0003BA3F9857

Endometrial Cancer NCT00807768 Toxicity - GOG-0249 Follow-Up Period Adverse Event Reporting Form - 2760083v1.0 - GOG-0249 Follow-Up Period Adverse Event Reporting Form

- 1/9/15 - 1 form, 4 itemgroups, 18 items, 1 language
Itemgroups: HEADER MODULE, ADVERSE EVENTS - SECTION 1, ADVERSE EVENTS - SECTION 2, COMMENTS
GOG-0249 Follow-Up Period Adverse Event Reporting Form Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FF32E53-FBDD-394B-E044-0003BA3F9857

Endometrial Cancer NCT00265759 Follow-Up - Z1031: Missed Visit Form - 2316588v3.0 - Z1031: Missed Visit Form

- 1/9/15 - 1 form, 3 itemgroups, 10 items, 1 language
Itemgroups: Header Module, Header, Footer Module
Z1031: Missed Visit Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FAD4E3B9-30EF-72AE-E034-0003BA3F9857

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial